These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16892039)

  • 1. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli.
    Tapinos N; Ohnishi M; Rambukkana A
    Nat Med; 2006 Aug; 12(8):961-6. PubMed ID: 16892039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinases: maiming myelin in leprosy.
    Franklin RJ; Zhao C
    Nat Med; 2006 Aug; 12(8):889-90. PubMed ID: 16892032
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating leprosy: an Erb-al remedy?
    Noon LA; Lloyd AC
    Trends Pharmacol Sci; 2007 Mar; 28(3):103-5. PubMed ID: 17276519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usage of signaling in neurodegeneration and regeneration of peripheral nerves by leprosy bacteria.
    Rambukkana A
    Prog Neurobiol; 2010 Jun; 91(2):102-7. PubMed ID: 20005916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.
    Tapinos N; Rambukkana A
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9188-93. PubMed ID: 15967991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.
    Rambukkana A; Zanazzi G; Tapinos N; Salzer JL
    Science; 2002 May; 296(5569):927-31. PubMed ID: 11988579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases.
    Vardhini D; Suneetha S; Ahmed N; Joshi DS; Karuna S; Magee X; Vijayalakshmi DS; Sridhar V; Karunakar KV; Archelos JJ; Suneetha LM
    Infect Genet Evol; 2004 Mar; 4(1):21-8. PubMed ID: 15019586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
    Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
    Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
    Yuste L; Montero JC; Esparís-Ogando A; Pandiella A
    Cancer Res; 2005 Aug; 65(15):6801-10. PubMed ID: 16061662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide modulates Mycobacterium leprae-induced NF-κB pathway and lower cytokine response.
    Hernandez Mde O; Fulco Tde O; Pinheiro RO; Pereira Rde M; Redner P; Sarno EN; Lopes UG; Sampaio EP
    Eur J Pharmacol; 2011 Nov; 670(1):272-9. PubMed ID: 21925494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium leprae-induced demyelination: a model for early nerve degeneration.
    Rambukkana A
    Curr Opin Immunol; 2004 Aug; 16(4):511-8. PubMed ID: 15245748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of extracellular signal-regulated kinase in sciatic nerve contributes to neuropathic pain after partial sciatic nerve ligation in mice.
    Kiguchi N; Maeda T; Kobayashi Y; Fukazawa Y; Kishioka S
    Anesth Analg; 2009 Oct; 109(4):1305-11. PubMed ID: 19762761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
    Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
    Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts.
    Mellinghoff IK; Tran C; Sawyers CL
    Cancer Res; 2002 Sep; 62(18):5254-9. PubMed ID: 12234993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.
    Xia W; Mullin RJ; Keith BR; Liu LH; Ma H; Rusnak DW; Owens G; Alligood KJ; Spector NL
    Oncogene; 2002 Sep; 21(41):6255-63. PubMed ID: 12214266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-binding prediction for ErbB2, a key molecule in the pathogenesis of leprosy.
    Wiwanitkit V
    Indian J Dermatol Venereol Leprol; 2008; 74(1):32-4. PubMed ID: 18187820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microanatomy of axon/glial signaling during Wallerian degeneration.
    Guertin AD; Zhang DP; Mak KS; Alberta JA; Kim HA
    J Neurosci; 2005 Mar; 25(13):3478-87. PubMed ID: 15800203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.